OSMR and ovarian cancer: Given that the receptors and ligands that activate the autocrine signaling through OSMR are highly expressed in cisplatin-resistant ovarian cancer cells, we sought to determine the level of OSMR/IL6ST heterodimerization in the cisplatin resistant cells compared to the sensitive cells.